Pancreatic Cancer Research

ResearcherIstanbul UniversityNo recent work listed

Derya Duranyıldız

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8866-5573; OpenAlex author ID A5077442313. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper

Papers 3

  1. Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy. Last author DOI 10.1007/s00280-014-2450-8↗
  2. Clinical significance of coagulation assays in metastatic pancreatic adenocarcinoma. Last author DOI 10.1007/s12029-013-9512-8↗
  3. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma. Last author DOI 10.1007/s13277-013-0931-8↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Faruk Taş · 3 shared papers, 2013–2014 · strength 0.13
  2. Senem Karabulut · 3 shared papers, 2013–2014 · strength 0.13
  3. İbrahim Yıldız · 1 shared paper, 2013 · strength 0.04
  4. Didem Taştekin · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.